Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
This program does not meet the proficiency testing requirements for laboratories subject to US regulations and CAP-accredited laboratories that are performing non-waived testing.
For multiple instrument reporting options, see the Quality Cross Check program, COV2Q.
Program Information
- Three 1.5-mL liquid simulated respiratory specimens
- Designed for molecular techniques
- Qualitative reporting options available
- Whole genome with sequence targets across all assay platforms
Shipping Schedule
- Shipment A: February 18
- Shipment B: May 18